Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Patscheke

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Thrombosis and Haemostasis|August 26, 1998
Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemiaA J Grau, A Ruf, A Vogt, et al.
British Journal of Haematology|July 1, 1997
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia majorA Ruf, M Pick, V Deutsch, et al.
Thrombosis Research|August 15, 1984
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drugK Stegmeier, J Pill, B Müller-Beckmann, et al.
Stroke|September 10, 1998
Prothrombin gene G20210-->A transition is a risk factor for cerebral venous thrombosisK H Reuner, A Ruf, A Grau, et al.
International Journal of Sports Medicine|August 21, 2001
Platelet activation through triathlon competition in ultra-endurance trained athletes: impact of thrombin and plasmin generation and catecholamine releaseM Möckel, N V Ulrich, G Heller, et al.
Biochemical and Biophysical Research Communications|October 24, 1995
In vivo degradation of human fibrinogen A alpha: detection of cleavage sites and release of antithrombotic peptidesL Ständker, R Sillard, K W Bensch, et al.
Thrombosis and Haemostasis|July 15, 2000
Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptorsM Gawaz, A Ruf, G Pogatsa-Murray, et al.
Neurology|January 9, 2008
Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosisK H Reuner, E Jenetzky, A Aleu, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Thrombosis and Haemostasis|August 26, 1998
Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemiaA J Grau, A Ruf, A Vogt, et al.
British Journal of Haematology|July 1, 1997
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia majorA Ruf, M Pick, V Deutsch, et al.
Thrombosis Research|August 15, 1984
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drugK Stegmeier, J Pill, B Müller-Beckmann, et al.
Stroke|September 10, 1998
Prothrombin gene G20210-->A transition is a risk factor for cerebral venous thrombosisK H Reuner, A Ruf, A Grau, et al.
International Journal of Sports Medicine|August 21, 2001
Platelet activation through triathlon competition in ultra-endurance trained athletes: impact of thrombin and plasmin generation and catecholamine releaseM Möckel, N V Ulrich, G Heller, et al.
Biochemical and Biophysical Research Communications|October 24, 1995
In vivo degradation of human fibrinogen A alpha: detection of cleavage sites and release of antithrombotic peptidesL Ständker, R Sillard, K W Bensch, et al.
Thrombosis and Haemostasis|July 15, 2000
Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptorsM Gawaz, A Ruf, G Pogatsa-Murray, et al.
Neurology|January 9, 2008
Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosisK H Reuner, E Jenetzky, A Aleu, et al.
Pageof 5